ANI Pharmaceuticals

Yahoo Finance • 24 days ago

ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise

PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that it has established The FutureVision Advisory Council to help guide the strategic advancement of its... Full story

Yahoo Finance • 25 days ago

ANI Pharmaceuticals Announces Board Transition

Patrick D. Walsh steps down as Chairman and will complete his current term as Board member Thomas J. Haughey has been unanimously elected to serve as the next Chairman of the Board PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- A... Full story

Yahoo Finance • last month

ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference

PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 37th... Full story

Yahoo Finance • last month

Relative Strength Alert For ANI Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 2 months ago

ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance

Record quarterly net revenues of $227.8 million, an increase of 53.6% year-over-yearPurified Cortrophin® Gel net revenues of $101.9 million, an increase of 93.8% year-over-yearRecord quarterly adjusted non-GAAP EBITDA of $59.6 million, an... Full story

Yahoo Finance • 2 months ago

ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET

PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its third quarter 2025 financial results on Friday, November 7, 2025, prior to... Full story

Yahoo Finance • 2 months ago

ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting

PRINCETON, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that results from the NEW DAY clinical trial of ILUVIEN® (fluocinolone acetonide intravitreal implant),... Full story

Yahoo Finance • 3 months ago

Carlyle Group Reaches Analyst Target Price

In recent trading, shares of Carlyle Group Inc (Symbol: CG) have crossed above the average analyst 12-month target price of $40.27, changing hands for $40.96/share. When a stock reaches the target an analyst has set, the analyst logicall... Full story

Yahoo Finance • 4 months ago

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Shows Strong Momentum and Growth, Fitting Minervini's Trend-Following Criteria

ANI Pharmaceuticals Inc (NASDAQ:ANIP [https://www.chartmill.com/stock/quote/ANIP]) has become an interesting candidate for investors using Mark Minervini's trend-following method combined with high-growth momentum screening. The approach f... Full story

Yahoo Finance • 4 months ago

ANI Pharmaceuticals to Present at Upcoming Investor Conferences

PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executiv... Full story

Yahoo Finance • 4 months ago

Ani Pharmaceuticals stock hits 52-week high at 90.43 USD

ANI Pharmaceuticals (NASDAQ:ANIP) Inc. (market cap: $1.8 billion) has reached a significant milestone as its stock hit a 52-week high of 90.43 USD. According to InvestingPro data, the company has demonstrated impressive revenue growth of n... Full story

Yahoo Finance • 4 months ago

Ani Pharmaceuticals SVP Carey sells $4.3m in shares

Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals Inc (NASDAQ:ANIP), sold 50,000 shares of common stock on August 12, 2025, at a price of $86.07, totaling $4,303,500. On the same day, Carey also exercised options to acquire 50,000 shares... Full story

Yahoo Finance • 4 months ago

Ani Pharmaceuticals’ Cook sells $35k in stock

Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals Inc (NASDAQ:ANIP), sold 400 shares of common stock on August 13, 2025, at a price of $88.87, for a total transaction value of $35548. Following the transaction, Cook dir... Full story

Yahoo Finance • 4 months ago

Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock

Thomas Andrew Rowland, SVP, HEAD - ESTABLISHED BRANDS at ANI Pharmaceuticals Inc (NASDAQ:ANIP), sold 4,975 shares of common stock on August 12, 2025, for approximately $426,407. The shares were sold in multiple transactions at prices rangi... Full story

Yahoo Finance • 4 months ago

ANI Pharmaceuticals stock price target raised to $77 from $65 at Truist Securities

Investing.com - Truist Securities raised its price target on ANI Pharmaceuticals (NASDAQ:ANIP) to $77.00 from $65.00 on Monday, while maintaining a Hold rating on the stock. The company’s shares have surged 24.53% in the past week, reachin... Full story

Yahoo Finance • 5 months ago

ANI Pharmaceuticals raises 2025 guidance to $843M revenue and $7.35 EPS as Cortrophin Gel accelerates

Earnings Call Insights: ANI Pharmaceuticals (ANIP) Q2 2025 MANAGEMENT VIEW * President and CEO Nikhil Lalwani described Q2 2025 as a "record-setting quarter for our company with all-time overall company highs in net revenue, adjusted n... Full story

Yahoo Finance • 5 months ago

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

CG Oncology Inc. - Announced best-in-disease durability data in BOND-003 Cohort C and promising early signal in Cohort P for cretostimogene grenadenorepvec at the American Urological Association Annual Meeting - - Initiated CORE-008 Coho... Full story

Yahoo Finance • 5 months ago

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Reports Record Q2 2025 Earnings, Beats Estimates and Raises Full-Year Guidance

ANI Pharmaceuticals Inc (NASDAQ:ANIP [https://www.chartmill.com/stock/quote/ANIP/profile]) reported record financial results for the second quarter of 2025, significantly exceeding analyst expectations. The company also raised its full-yea... Full story

Yahoo Finance • 5 months ago

ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance

Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on an organic basisTotal Rare Disease quarterly net revenues of $104.0 million, which includes: Purified... Full story

Yahoo Finance • 5 months ago

ANI Pharmaceuticals Q2 2025 Earnings Preview

* ANI Pharmaceuticals (NASDAQ:ANIP [https://seekingalpha.com/symbol/ANIP]) is scheduled to announce Q2 earnings results on Friday, August 8th, before market open. The consensus EPS Estimate is $1.42 [https://seekingalpha.com/symbol/ANIP... Full story